本页面由Tiger Trade Technology Pte. Ltd.提供服务

Immix Biopharma, Inc

8.81
-0.4400-4.76%
成交量:81.35万
成交额:718.66万
市值:7.32亿
市盈率:-10.16
高:9.29
开:9.10
低:8.66
收:9.25
52周最高:15.10
52周最低:2.31
股本:8,307.92万
流通股本:7,032.70万
量比:1.12
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-0.8667
每股收益(LYR):-0.8930
净资产收益率:-34.18%
总资产收益率:-20.52%
市净率:3.20
市盈率(LYR):-9.87

数据加载中...

2026/09/30

重要事件披露

Form 8-K - Current report
2026/09/29

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/09/29

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/20

重要事件披露

Form 8-K - Current report
2026/06/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/21

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/03/27

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/25

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]